These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20090920)

  • 1. 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
    Riedel M; Goldbaum O; Schwarz L; Schmitt S; Richter-Landsberg C
    PLoS One; 2010 Jan; 5(1):e8753. PubMed ID: 20090920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
    Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of α-synuclein in oligodendroglial cells.
    Pukaß K; Goldbaum O; Richter-Landsberg C
    J Neurochem; 2015 Oct; 135(1):194-205. PubMed ID: 26212128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Hsp90 Inhibitor Activates Compensatory Heat Shock Protein Responses and Autophagy and Alleviates Mutant A53T α-Synuclein Toxicity.
    Xiong R; Zhou W; Siegel D; Kitson RR; Freed CR; Moody CJ; Ross D
    Mol Pharmacol; 2015 Dec; 88(6):1045-54. PubMed ID: 26405178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab7 induces clearance of α-synuclein aggregates.
    Dinter E; Saridaki T; Nippold M; Plum S; Diederichs L; Komnig D; Fensky L; May C; Marcus K; Voigt A; Schulz JB; Falkenburger BH
    J Neurochem; 2016 Sep; 138(5):758-74. PubMed ID: 27333324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress.
    Riedel M; Goldbaum O; Richter-Landsberg C
    J Mol Neurosci; 2009 Sep; 39(1-2):226-34. PubMed ID: 19266322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes.
    Schwarz L; Goldbaum O; Bergmann M; Probst-Cousin S; Richter-Landsberg C
    J Mol Neurosci; 2012 Jun; 47(2):256-66. PubMed ID: 22411133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
    Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X
    Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome.
    Petroi D; Popova B; Taheri-Talesh N; Irniger S; Shahpasandzadeh H; Zweckstetter M; Outeiro TF; Braus GH
    J Biol Chem; 2012 Aug; 287(33):27567-79. PubMed ID: 22722939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17-AAG post-treatment ameliorates memory impairment and hippocampal CA1 neuronal autophagic death induced by transient global cerebral ischemia.
    Li J; Yang F; Guo J; Zhang R; Xing X; Qin X
    Brain Res; 2015 Jun; 1610():80-8. PubMed ID: 25858486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
    Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L
    PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress.
    Riedel M; Goldbaum O; Wille M; Richter-Landsberg C
    J Mol Neurosci; 2011 Mar; 43(3):290-302. PubMed ID: 20725866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy.
    Sheng YL; Chen X; Hou XO; Yuan X; Yuan BS; Yuan YQ; Zhang QL; Cao X; Liu CF; Luo WF; Hu LF
    Exp Neurol; 2017 Nov; 297():138-147. PubMed ID: 28821398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.
    Pukaß K; Richter-Landsberg C
    Front Cell Neurosci; 2015; 9():163. PubMed ID: 25999815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level.
    Yu W; Rao Q; Wang M; Tian Z; Lin D; Liu X; Wang J
    Leuk Res; 2006 May; 30(5):575-82. PubMed ID: 16213582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates.
    Arawaka S; Sato H; Sasaki A; Koyama S; Kato T
    Acta Neuropathol Commun; 2017 Jun; 5(1):48. PubMed ID: 28619113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines.
    Massimini M; Palmieri C; De Maria R; Romanucci M; Malatesta D; De Martinis M; Maniscalco L; Ciccarelli A; Ginaldi L; Buracco P; Bongiovanni L; Della Salda L
    Vet Pathol; 2017 May; 54(3):405-412. PubMed ID: 28438108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FYCO1 mediates clearance of α-synuclein aggregates through a Rab7-dependent mechanism.
    Saridaki T; Nippold M; Dinter E; Roos A; Diederichs L; Fensky L; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Aug; 146(4):474-492. PubMed ID: 29747217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.
    Emmanouilidou E; Stefanis L; Vekrellis K
    Neurobiol Aging; 2010 Jun; 31(6):953-68. PubMed ID: 18715677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
    Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
    J Mol Med (Berl); 2006 Aug; 84(8):635-46. PubMed ID: 16741751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.